Want to see SINT full AI Analyst Report?
SINT Stock Chart & Stats
$1.58
-$0.35(-9.09%)
At close: 4:00 PM EST
$1.58
-$0.35(-9.09%)
Day’s Range― - ―
52-Week Range$1.40 - $4.46
Previous CloseN/A
Volume24.46K
Average Volume (3M)71.69K
Market Cap
$13.00M
Enterprise Value$8.63M
Total Cash (Recent Filing)$3.59M
Total Debt (Recent Filing)$3.05M
Price to Earnings (P/E)―
Beta2.31
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding7,558,073
10 Day Avg. Volume54,077
30 Day Avg. Volume71,695
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)3.66
Price to Sales (P/S)10.52
P/FCF Ratio-1.22
Enterprise Value/Market Cap0.66
Enterprise Value/Revenue6.25
Enterprise Value/Gross Profit-134.82
Enterprise Value/Ebitda-0.81
Forecast
1Y Price Target
$9.50Price Target Upside501.27% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Margin ImprovementThe sharp improvement in quarterly revenue and gross margin indicates stronger product traction and a more favorable sales mix. If maintained beyond the small current base, better margins could support reinvestment, reduce operating losses, and improve the scalability of commercialization.
Commercialized FDA-Cleared ProductFDA clearance and initial clinical use move SiNAPTIC from development toward commercial adoption. The product’s regulatory milestone and early revenue provide a foundation for broader orthopedic distribution, customer validation, and potentially recurring demand as clinical use expands.
Industrial Order DiversificationIndustrial ceramics orders add a second commercial pathway alongside medical products and can diversify revenue while orthopedic programs mature. Shipments to aerospace-related customers also demonstrate practical demand for the platform and could support a broader commercial base.
Bears Say
Persistent Cash BurnSustained negative operating and free cash flow means the business is not yet funding itself internally. Continued burn can constrain investment in commercialization, require repeated external financing, and leave the company more exposed if revenue growth or order execution slows.
Liquidity And Going-Concern RiskThe low cash balance relative to ongoing losses and operating needs creates a material funding challenge over the next several quarters. Dependence on additional equity or debt financing may dilute existing holders, increase financial pressure, and limit strategic flexibility.
Uncertain Order ConversionPurchase orders improve potential visibility but do not guarantee recognized revenue or cash receipts. Multiple technical and customer milestones can delay conversion, making reported revenue uneven and increasing the risk that recent commercial momentum does not translate into durable results.
SINT FAQ
What was Sintx Technologies Inc’s price range in the past 12 months?
Sintx Technologies Inc lowest stock price was $1.40 and its highest was $4.46 in the past 12 months.
What is Sintx Technologies Inc’s market cap?
Sintx Technologies Inc’s market cap is $13.00M.
When is Sintx Technologies Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Sintx Technologies Inc’s earnings last quarter?
Currently, no data Available
Is Sintx Technologies Inc overvalued?
According to Wall Street analysts Sintx Technologies Inc’s price is currently Undervalued.
Does Sintx Technologies Inc pay dividends?
Sintx Technologies Inc does not currently pay dividends.
What is Sintx Technologies Inc’s EPS estimate?
Sintx Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sintx Technologies Inc have?
Sintx Technologies Inc has 7,558,073 shares outstanding.
What happened to Sintx Technologies Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Sintx Technologies Inc?
Currently, no hedge funds are holding shares in SINT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sintx Technologies Inc
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
SINT Earnings Call
Q2 2026
0:00 / 0:00
SINT Stock 12 Month Forecast
Average Price Target
$9.50
▲(501.27% Upside)
Technical Analysis
Integra Lifesciences
―
Medtronic
―
Orthofix Medical
―
Stryker
―
Zimmer Biomet Holdings
―
Ownership Overview
3.53% Insiders
0.61% Mutual Funds
1.01% Other Institutional Investors
94.57% Public Companies and
Individual Investors








